Galera Therapeutics, Inc. (GRTX) › Net IncomeGalera Therapeutics, Inc. (GRTX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$23.68M2019: -$51.93M2020: -$74.22M2021: -$80.53M2022: -$62.22M2023: -$59.08M2024: -$18.96M2025: $149.05M$149.05M2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$149.05M+886.2%2024-$18.96M+67.9%2023-$59.08M+5.0%2022-$62.22M+22.7%2021-$80.53M-8.5%2020-$74.22M-42.9%2019-$51.93M-119.3%2018-$23.68M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share